Skip to content
Recall Observatory FDA recall evidence

Drug product

Lidocaine HCl/Phenylephrine HCl Nasal Solution, 4%/1%, 240 mL per bottle, Multiple Dose Container, Edge Pharma, LLC 856 Hercules Dr., Colchester, VT 05446, NDC 05446-1045-03

D-0444-2022

December 06, 2021

Class II

Product summary

Firm
Edge Pharma, LLC
Event
Event 89172
Status
Terminated
Classification
Class II
Quantity
231 bottles
Official record key
drug-enforcement:D-0444-2022

Official wording

Reason: CGMP Deviations

Code information: 07-2021-02@7 12-29-2021, 07-2021-23@4 01-19-2022, 08-2021-11@7 02-07-2022, 08-2021-23@8 02-19-2022 & 09-2021-24@10 03-23-2022

Distribution pattern: nationwide

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations